Bharat Parenterals reports strong financial performance for quarter and half year

Bharat Parenterals Limited reported a substantial increase in its unaudited financial results for the quarter ended September 30, 2025. Total income from operations surged to INR 3,375.00 lakhs from INR 2,058.40 lakhs in the same quarter of the previous year. Profit Before Tax (PBT) also saw a significant jump, reaching INR 380.00 lakhs compared to INR 127.80 lakhs, while Profit After Tax (PAT) climbed to INR 276.00 lakhs from INR 94.60 lakhs year-on-year.

For the half year ended September 30, 2025, the company maintained its upward trajectory. Total income from operations stood at INR 6,192.80 lakhs, a considerable rise from INR 3,786.72 lakhs reported in the corresponding half year of the previous fiscal. PBT for the half year increased to INR 704.90 lakhs from INR 286.70 lakhs, and PAT grew to INR 546.50 lakhs from INR 213.90 lakhs.

The company's basic and diluted earnings per share (EPS) also reflected this strong performance, with basic EPS for the quarter reaching INR 1.70 from INR 0.58 in the prior year's quarter. For the half year, basic EPS was INR 3.37, up from INR 1.32. These results were approved by the board of directors at their meeting held on November 12, 2025.